Propanc Biopharma to Host Corporate Update Call Highlighting Recent Progress and Positive Results from Compassionate Use Study

MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering

Related Keywords

Melbourne ,Victoria ,Australia ,Julian Kenyon ,James Nathanielsz ,Klaus Kutz ,Company Mechanism Of Action ,Drug Administration ,Propanc Biopharma Inc ,Propanc Biopharma ,Chief Scientific Officer ,Acting Chief Medical ,Ralf Brandt Phd ,Scientific Advisory Board Member ,Chief Executive Officer ,Executive Chairman ,Chief Financial ,Drug Designation ,Looking Statements ,Private Securities Litigation Reform Act ,Media Contacts ,Press Release , ,